Efavirenz-associated severe hyperlipidemia

被引：11

作者：

Bonnet, F ^{[1
]}

Bonarek, M ^{[1
]}

de Witte, S ^{[1
]}

Beylot, J ^{[1
]}

Morlat, P ^{[1
]}

机构：

[1] Hop St Andre, Serv Med Interne & Malad Infect, F-33075 Bordeaux, France

来源：

CLINICAL INFECTIOUS DISEASES | 2002年 / 35卷 / 06期

关键词：

D O I：

10.1086/342326

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

引用

页码：776 / 777

页数：2

共 7 条

[1] Gynecomastia without lipodystrophy syndrome in HIV-infected men treated with efavirenz [J].

Caso, JAA ;

Prieto, JD ;

Casas, E ;

Sanz, J .

AIDS, 2001, 15 (11) :1447-1448

[2]

Doser N, 2001, J ACQ IMMUN DEF SYND, V26, P389, DOI 10.1097/00126334-200104010-00018

[3]

Koppel K, 2000, AIDS, V14, pS55

[4] Impact of switching from human immunodeficiency virus type 1 protease inhibitors to efavirenz in successfully treated adults with lipodystrophy [J].

Martínez, E ;

García-Viejo, MA ;

Blanco, JL ;

Bianchi, L ;

Buira, E ;

Conget, I ;

Casamitjana, R ;

Mallolas, J ;

Gatell, JM .

CLINICAL INFECTIOUS DISEASES, 2000, 31 (05) :1266-1273

[5] Efavirenz-associated breast hypertrophy in HIV-infected patients [J].

Mercié, P ;

Viallard, JF ;

Thiébaut, R ;

Faure, I ;

Rispal, P ;

Leng, B ;

Pellegrin, JL .

AIDS, 2001, 15 (01) :126-129

[6] Once-daily combination therapy with emtricitabine, didanosine, and efavirenz in human immunodeficiency virus-infected patients [J].

Molina, JM ;

Ferchal, F ;

Rancinan, C ;

Raffi, F ;

Rozenbaum, W ;

Sereni, D ;

Morlat, P ;

Journot, V ;

Decazes, JM ;

Chêne, G .

JOURNAL OF INFECTIOUS DISEASES, 2000, 182 (02) :599-602

[7]

RUIZ NM, 1991, 6 C RETR OPP INF CHI, P191

← 1 →